Assessment of the effective factors for returning to work among dental students during the COVID-19 pandemic
Abstract
Occupation incapacity imposes a massive economic burden on society, which results in individual, social and economic consequences during the coronavirus disease 2019 (COVID-19) pandemic. In this regard, we decided to investigate the effective factors for returning to work among dental students under the influence of the COVID-19 pandemic. This cross-sectional study was conducted from September to November 2021. Demographical data, clinical characteristics, and duration of return to work of dental students of Guilan University of Medical Sciences, Bandar Anzali, Iran, who were working in the dental clinic during the COVID-19 pandemic and willing to participate in the study, were collected. The mean duration of return to work was 7.18 ± 3.29 months. Gender was related to the duration of return to work with the mean of 9.17± 4.89 months in males, and 6.25± 1.63 months in females. Body mass index (BMI) was reported as a related factor to the duration of return to work, consequently by increasing the BMI, the duration of returning to work also increases. Age, underlying disease, academic year (fifth or sixth), COVID-19 infection, duration of hospitalization, recovery duration, and physical and psychological status were not related to the duration of returning to work. In this study, complete readiness to return to work was 62.5%. Also, gender and BMI were determined as the most significant factors that related to the duration of return to work.
Keywords
Full Text:
Full-text PDFReferences
Zhang S-F, Tuo J-L, Huang X-B, Zhu X, Zhang D-M, Zhou K, et al. Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou. PLoS One. 2018; 13(1):e0191789.
Trojánek M, Grebenyuk V, Herrmannová K, Nečas T, Gregorová J, Kucbel M, et al. A novel coronavirus (SARS-CoV-2) and COVID-19. Cas Lek Cesk. 2020; 159(2):55–66.
Huston CD, Petri WA. Host-pathogen interaction in amebiasis and progress in vaccine development. Eur J Clin Microbiol Infect Dis. 1998; 17(9):601–14.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061–9.
Halaji M, Heiat M, Faraji N, Ranjbar R. Epidemiology of COVID-19: An updated review. J Res Med Sci. 2021; 30;26:82.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054–62.
Zhang C, Wu Z, Li J-W, Zhao H, Wang G-Q. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020; 55(5):105954.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 15;395(10223):497–506.
Lu C-W, Liu X-F, Jia Z-F. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020; 395(10224):e39.
Adhikari SP, Meng S, Wu Y-J, Mao Y-P, Ye R-X, Wang Q-Z, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis poverty. 2020; 17;9(1):29.
Sun P, Qie S, Liu Z, Ren J, Li K, Xi J. Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis. J Med Virol. 2020; 92(6):612-7.
Extance A. Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease? Bmj. 2020; 368:m1174.
Mao R, Liang J, Shen J, Ghosh S, Zhu L-R, Yang H, et al. Implications of COVID-19 for patients with pre-existing digestive diseases. lancet Gastroenterol Hepatol. 2020; 5(5):425–7.
El-Anwar MW, Elzayat S, Fouad YA. ENT manifestation in COVID-19 patients. Auris Nasus Larynx. 2020; 47(4):559–64.
Rassouli M, Ashrafizadeh H, Shirinabadi Farahani A, Akbari ME. COVID-19 Management in Iran as One of the Most Affected Countries in the World: Advantages and Weaknesses. Front Public Health. 2020; 8:510.
Coulthard P. Dentistry and coronavirus (COVID-19) - moral decision-making. Br Dent J. 2020; 228(7):503-5.
Bastani P, Mohammadpour M, Ghanbarzadegan A, Kapellas K, Do LG. Global concerns of dental and oral health workers during COVID-19 outbreak: a scope study on the concerns and the coping strategies. Syst Rev. 2021; 10(1):45.
Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey. Psychiatry Res. 2020; 288:112954.
Li Z, Ge J, Yang M, Feng J, Qiao M, Jiang R, et al. Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control. Brain Behav Immun. 2020; 88:916–9.
Rafeemanesh E, Rahimpour F, Ahmadi F. Return to Work in COVID-19: Review of Current Guidelines. Iran Occup Health J. 2020; 17(S1):55-65.
Darenhal M, Attarchi M, Seyed Mehdi SM, Rahimiyan A, Yazdanparast T. Factors affecting return to work after lumbar disc herniation surgery. Razi J Med Sci. 2011; 18(90):7-16.
Sedighi M, Haghnegahdar A. Lumbar disk herniation surgery: outcome and predictors. Global Spine J. 2014; 4(4):233-44.
Rahimpour F. Patient’s Return To Work 3 Months After Lumbar Spine Discectomy And It’s Determinants In Mashhad 2015-2016: A Multicenter Cohort. Med J Mashhad Univ Med Sci. 2017;60(1):418–32.
Pélissier C, Fontana L, Chauvin F. Factors influencing return to work after illness in France. Occup Med (Lond). 2014; 64(1):56–63.
Oyeflaten I, Hysing M, Eriksen HR. Prognostic factors associated with return to work following multidisciplinary vocational rehabilitation. J Rehabil Med. 2008; 40(7):548–54.
Refbacks
- There are currently no refbacks.
Copyright (c) 2022 © The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.